Employers & Consultants
![Line Art 1](https://prescryptive.com/wp-content/themes/prescryptive/images/flag_outline.png)
![Line Art 2](https://prescryptive.com/wp-content/themes/prescryptive/images/flag_outline.png)
![Line Art 3](https://prescryptive.com/wp-content/themes/prescryptive/images/flag_outline.png)
![Line Art 4](https://prescryptive.com/wp-content/themes/prescryptive/images/flag_outline.png)
The new financial model aims to provide price transparency while encouraging medication adherence.
Asking these three questions about your pharmacy benefits plan can lead to bigger savings and a better member…
Prescryptive CEO, Chris Blackley, joins the Healthcare Americana podcast to discuss the root of the prescription drug pricing…
Partnership will offer a comprehensive and transparent experience for Transcarent Members.
Drug prices for commercial health plans could increase under the recently passed Inflation Reduction Act. HR must act…
Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…
As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…
Owning your pharmacy benefits data is a must. In her latest Benefits PRO article, Andrea Pickett, Prescryptive’s Chief…
“With his name, brand and reputation, it has created a lot of interest and appropriately put a brighter…
Hear what our co-founder and CEO, Chris Blackley, has to say about the recent FTC probe into the…
Keep reading in Benefits PRO: Prescription benefits: 3 things you should be discussing with your PBM consultant
Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies – MedCity News